RIPPLY3 is a transcriptional corepressor that functions as a negative regulator of TBX1, a key transcription factor in developmental patterning 1. Primary function: RIPPLY3 suppresses TBX1-induced transcriptional activation, thereby modulating gene expression during embryonic development 1. Mechanism: RIPPLY3 represses TBX1 activity through direct physical interaction and antagonizes polycomb group proteins via a conserved WRPW motif, facilitating transcriptional derepression 2. During pharyngeal apparatus development, RIPPLY3 expression overlaps with TBX1 in the caudal pharyngeal endoderm, where it regulates Pax9 expression 1. Disease relevance: RIPPLY3 deficiency causes abnormal pharyngeal derivative development, including ectopic thymus and parathyroid formation, and cardiovascular malformations 1. Conversely, RIPPLY3 overdosage induces mid-face shortening through TBX1 downregulation in Down syndrome models, affecting branchial arch development and cell proliferation 3. Loss-of-function variants (p.T52S) in RIPPLY3 impair TBX1 interaction and represent genetic risk factors for conotruncal heart defects independent of 22q11.2 deletions 4. Clinical significance: RIPPLY3 variants contribute to congenital heart disease pathogenesis, and RIPPLY3 emerged as a hub gene associated with immune infiltration patterns in neuroendocrine prostate cancer 5.